Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001999480-24-000035
Filing Date
2024-08-13
Accepted
2024-08-13 16:36:57
Documents
67
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alto-20240630.htm   iXBRL 10-Q 1550081
2 EX-31.1 exhibit311-302certceo2q2024.htm EX-31.1 12911
3 EX-31.2 exhibit312-302certcfo2q2024.htm EX-31.2 12952
4 EX-32.1 exhibit321-906certceo2q2024.htm EX-32.1 8239
5 EX-32.2 exhibit322-906certcfo2q2024.htm EX-32.2 8250
11 alto-20240630_g1.jpg GRAPHIC 990720
  Complete submission text file 0001999480-24-000035.txt   8731575

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alto-20240630.xsd EX-101.SCH 53858
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alto-20240630_cal.xml EX-101.CAL 51595
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alto-20240630_def.xml EX-101.DEF 271927
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alto-20240630_lab.xml EX-101.LAB 568405
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alto-20240630_pre.xml EX-101.PRE 392672
70 EXTRACTED XBRL INSTANCE DOCUMENT alto-20240630_htm.xml XML 570026
Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41944 | Film No.: 241202300
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)